BIOMAT Database Logo BIOMAT Database Logo

Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial. 1977

A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen

Twenty-one patients suffering from the premenstrual syndrome were each studied during three menstrual cycles. After a control cycle, bromocriptine and placebo were given during the luteal phase of the cycle in a random double-blind cross-over manner, each patient serving as her own control. The dosage of bromocriptine was 2-5 mg twice daily. Serum prolactin levels were found to equal during the follicular and luteal phases, except when reduced by bromocriptine. Serum progesterone and oestradiol-17-beta were within normal ranges, and did not change during treatment. Medication considerably improved all the premenstrual symptoms, but mastodynia was the only one where bromocriptine was significantly better than the placebo.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011293 Premenstrual Syndrome A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses. Premenstrual Tension,Premenstrual Syndromes,Premenstrual Tensions,Syndrome, Premenstrual,Syndromes, Premenstrual,Tension, Premenstrual,Tensions, Premenstrual
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Effect of calcium on premenstrual syndrome: A double-blind randomized clinical trial.
January 2017, Obstetrics & gynecology science,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
A double blind trial of bromocriptine in the Rett syndrome.
January 1990, Brain & development,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Progesterone and the premenstrual syndrome: a double blind crossover trial.
July 1985, British medical journal (Clinical research ed.),
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Progesterone and the premenstrual syndrome: a double blind crossover trial.
June 1985, British medical journal (Clinical research ed.),
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Bromocriptine and premenstrual symptoms: a survey of double blind trials.
November 1983, Obstetrical & gynecological survey,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
January 1986, Journal of affective disorders,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Effectiveness of Echium amoenum on premenstrual syndrome: a randomized, double-blind, controlled trial.
September 2020, BMC complementary medicine and therapies,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Premenstrual syndrome: a double-blind controlled trial of desipramine and methylscopolamine.
June 1995, International clinical psychopharmacology,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
September 1979, The British journal of psychiatry : the journal of mental science,
A N Andersen, and J F Larsen, and O R Steenstrup, and B Svendstrup, and J Nielsen
Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
June 1993, Archives of general psychiatry,
Copied contents to your clipboard!